Showing results (1-10 of 431) with videos related to
Sort By:
Pageof 44
Theranostics|February 6, 2013
Involvement of CXCR4/CXCR7/CXCL12 Interactions in Inflammatory bowel diseaseLael Werner, Hanan Guzner-Gur, Iris DotanJournal of Crohn'S & Colitis|May 4, 2013
Antibodies against glycoprotein 2 are novel markers of intestinal inflammation in patients with an ileal pouchLael Werner, Andreas Sturm, Dirk Roggenbuck, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 15, 2012
Identification of pancreatic glycoprotein 2 as an endogenous immunomodulator of innate and adaptive immune responsesLael Werner, Daniela Paclik, Christina Fritz, et al.Advances in Clinical Chemistry|June 4, 2013
Glycoprotein 2 antibodies in Crohn's diseaseDirk Roggenbuck, Dirk Reinhold, Lael Werner, et al.Digestive Diseases and Sciences|September 5, 2020
Antibodies Against Glycoprotein 2 Are Specific Biomarkers for Pediatric Crohn's DiseaseMichael Shpoliansky, Dirk Roggenbuck, Marina Pinsker, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|July 22, 2026
Reduced fecal GP2 levels in ulcerative colitis associate with inflammatory activity and microbial compositionYoav Uchitel, Dirk Roggenbuck, Haim Leibovitzh, et al.Journal of Leukocyte Biology|June 2, 2011
Reciprocal regulation of CXCR4 and CXCR7 in intestinal mucosal homeostasis and inflammatory bowel diseaseLael Werner, Hofit Elad, Eli Brazowski, et al.Inflammatory Bowel Diseases|September 24, 2009
CXCL12 is a constitutive and inflammatory chemokine in the intestinal immune systemIris Dotan, Lael Werner, Sharon Vigodman, et al.Digestive Diseases (Basel, Switzerland)|October 8, 2010
New serologic markers for inflammatory bowel disease diagnosisIris DotanHarefuah|December 23, 2006
[Inflammatory bowel diseases: in search of novel cytokines and genes]Iris DotanPageof 44